Summit Creek Advisors’s OptimizeRx OPRX Stock Holding History

Summit Creek Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-193,224	Closed	-$3.25M	–	75
2022 Q4	$3.25M	Sell	193,224 -95,779	-33%	-$1.66M	0.44%	53
2022 Q3	$4.28M	Sell	289,003 -9,476	-3%	-$187K	0.59%	48
2022 Q2	$8.18M	Buy	298,479 +81,286	+37%	+$2.41M	1.04%	42
2022 Q1	$8.19M	Buy	+217,193	New	+$9.61M	0.93%	45

Other funds holding OPRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Creek Advisors's OPRX Position: Q1 2023 in Review

Summit Creek Advisors sold out of OptimizeRx (OPRX) in Q1 2023, closing a stake of 193,224 shares — an estimated $3.25M sold.

Summit Creek Advisors first reported a position in OPRX in Q1 2022 and held it in 4 quarters. The position peaked at $8.19M in Q1 2022. 110 funds tracked by Wall St. Rank hold OPRX as of Q1 2023.

Summit Creek Advisors reported no remaining OptimizeRx position as of Q1 2023 after selling out during the quarter.
Summit Creek Advisors sold 193,224 OptimizeRx shares in Q1 2023, an estimated $3.25M.
Summit Creek Advisors first reported a position in OptimizeRx in Q1 2022 and held it in 4 quarters.
Summit Creek Advisors's OptimizeRx position peaked at $8.19M in Q1 2022.
110 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2023.

Based on Summit Creek Advisors's 13F filing for Q1 2023, filed 5 May 2023.